Meneghel Alessandra, Masenello Valentina, Alfier Fiorenza, Giampetruzzi Stefania, Sembenini Camilla, Martini Giorgia, Tirelli Francesca, Meneghesso Davide, Zulian Francesco
Pediatric Rheumatology Unit, Department for Woman and Child's Health, University of Padua, 35128 Padua, Italy.
Pediatric Nephrology Unit, Department for Woman and Child's Health, University of Padua, 35128 Padua, Italy.
Children (Basel). 2023 Oct 7;10(10):1661. doi: 10.3390/children10101661.
Kidney involvement has been poorly investigated in SARS-CoV-2 Multisystem Inflammatory Syndrome in Children (MIS-C). To analyze the spectrum of renal involvement in MIS-C, we performed a single-center retrospective observational study including all MIS-C patients diagnosed at our Pediatric Department between April 2020 and May 2022. Demographic, clinical, pediatric intensive care unit (PICU) admission's need and laboratory data were collected at onset and after 6 months. Among 55 MIS-C patients enrolled in the study, kidney involvement was present in 20 (36.4%): 13 with acute kidney injury (AKI) and 7 with isolated tubular dysfunction (TD). In eight patients, concomitant AKI and TD was present (AKI-TD). AKI patients needed higher levels of intensive care (PICU: 61.5%, < 0.001; inotropes: 46.2%, = 0.002; second-line immuno-therapy: 53.8%, < 0.001) and showed lower levels of HCO3- ( = 0.012), higher inflammatory markers [neutrophils ( = 0.092), PCT ( = 0.04), IL-6 ( = 0.007)] as compared to no-AKI. TD markers showed that isolated TD presented higher levels of HCO3- and lower inflammatory markers than AKI-TD. Our results indicate a combination of both pre-renal and inflammatory damage in the pathogenesis of kidney injury in MIS-C syndrome. We highlight, for the first time, the presence of tubular involvement in MIS-C, providing new insights in the evaluation of kidney involvement and its management in this condition.
儿童新型冠状病毒2型多系统炎症综合征(MIS-C)中肾脏受累情况的研究较少。为分析MIS-C中肾脏受累的范围,我们进行了一项单中心回顾性观察研究,纳入了2020年4月至2022年5月在我们儿科诊断的所有MIS-C患者。收集了发病时和6个月后的人口统计学、临床、儿科重症监护病房(PICU)入院需求及实验室数据。在纳入研究的55例MIS-C患者中,20例(36.4%)存在肾脏受累:13例有急性肾损伤(AKI),7例有孤立性肾小管功能障碍(TD)。8例患者同时存在AKI和TD(AKI-TD)。与无AKI患者相比,AKI患者需要更高水平的重症监护(PICU:61.5%,<0.001;血管活性药物:46.2%,=0.002;二线免疫治疗:53.8%,<0.001),且HCO3-水平较低(=0.012),炎症标志物水平较高[中性粒细胞(=0.092)、降钙素原(=0.04)、白细胞介素-6(=0.007)]。TD标志物显示,孤立性TD的HCO3-水平高于AKI-TD,炎症标志物水平低于AKI-TD。我们的结果表明,在MIS-C综合征肾损伤的发病机制中存在肾前性和炎症性损伤的联合作用。我们首次强调了MIS-C中存在肾小管受累,为评估这种情况下的肾脏受累及其管理提供了新的见解。